Browse the complete record of transactions filed by Jacobs Jeffrey W, Directeur Scientifique. Insider active across 1 companies, notably Ardelyx, INC.. In total, 14 reports have been logged. Total volume traded: €33k. The latest transaction was disclosed on 22 November 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Jeffrey W. Jacobs is the Chief Scientific Officer at Ardelyx, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is essential in guiding Ardelyx's innovative projects, which focus on treatments for gastrointestinal diseases.